Ipsum Pharmaceuticals Private Limited
About Ipsum Pharmaceuticals Private Limited
Data last updated:
Ipsum Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PTC082077. Its GSTIN is 36AADCI1460N1ZF (Telangana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹47 Lakh. It is led by directors including Palla Aparna and Shyamala Budda.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068.
As per the financials filed for FY 2021, the company reported a revenue of ₹55.01 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.12 Lakh (net margin 2%) and EBITDA of ₹4.3 Lakh (EBITDA margin 7.8%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ipsum Pharmaceuticals Private Limited
The main business activity of Ipsum Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ipsum Pharmaceuticals Private Limited FY 2021 filings available
Ipsum Pharmaceuticals Private Limited reported revenue of ₹55.01 Lakh (down 28% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Ipsum Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 28% fall in the latest year. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ipsum Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.3 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.12 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ipsum Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ipsum Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eos Pharmaceuticals India Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Symbiosis Labs Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Wilfred Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Aurangabad, Maharashtra, India |
| Xenex Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| Qristol Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Dehradun, Uttarakhand, India |
| Ipsum Pharmaceuticals Private Limited this company | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Blucure Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Delhi, India |
| South Indo Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Mandya, Karnataka, India |
| Lift Life Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
| Atr Emergency Rescuers Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Synergy Pharmasource Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Ipsum Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals Private Limited is audited by JANGAM & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JANGAM & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Palla Aparna | Director | 20 Jul 2012 | 14 Years 2 Months | Current |
| Shyamala Budda | Director | 20 Jul 2012 | 14 Years 2 Months | Current |
| Appala Shashikala | Director | 20 Jul 2012 | 14 Years 2 Months | Current |
| Abhishek Budda | Director | 20 Jul 2012 | 14 Years 2 Months | Current |
| Narender Rao Kalakuntla Also directs: Zovalta Pharmaceuticals Private Limited | Director | 20 Jul 2012 | 14 Years 2 Months | Current |
Ownership and Shareholding of Ipsum Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ipsum Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ipsum Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2012PTC082077. The current CIN is U24232TG2012PTC082077, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PTC082077 | Current |
| U24232AP2012PTC082077 | Previous |
Recent Activity on Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals Private Limited has 5 board changes on record since 2012: 5 appointments. The latest: Abhishek Budda was appointed as Director on 20 Jul 2012.
Credit Ratings, Litigation & Regulatory Alerts for Ipsum Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ipsum Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ipsum Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCI1460N1ZF | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ipsum Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ipsum Pharmaceuticals Private Limited
Ipsum Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 July 2012 (14+ years old) and is registered under CIN U24232TG2012PTC082077.
Ipsum Pharmaceuticals reported revenue of ₹55.01 Lakh for FY 2021 (down 28% YoY).
Ipsum Pharmaceuticals has 5 current directors:
- Palla Aparna - Director
- Shyamala Budda - Director
- Appala Shashikala - Director
- Abhishek Budda - Director
- Narender Rao Kalakuntla - Director
Ipsum Pharmaceuticals reported a net profit of ₹1.12 Lakh (net margin 2%) and EBITDA of ₹4.3 Lakh (EBITDA margin 7.8%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ipsum Pharmaceuticals is -22% over three years and -13% over five years. In the latest year (FY 2021) revenue fell 28%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ipsum Pharmaceuticals is 36AADCI1460N1ZF, registered in Telangana.
The CIN (Corporate Identification Number) of Ipsum Pharmaceuticals is U24232TG2012PTC082077. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ipsum Pharmaceuticals was incorporated on 20 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ipsum Pharmaceuticals by revenue are Eos Pharmaceuticals India Limited, Symbiosis Labs Private Limited, Wilfred Pharmaceuticals Private Limited, Xenex Pharmaceuticals Private Limited, Qristol Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Abhishek Budda was appointed as Director on 20 Jul 2012. Appala Shashikala was appointed as Director on 20 Jul 2012. Narender Rao Kalakuntla was appointed as Director on 20 Jul 2012. Ipsum Pharmaceuticals has 5 board changes on record in total.
The registered office of Ipsum Pharmaceuticals is at Plot No 101 & 102A Road No 4 Raghavendra Nagar Bandlaguda Nagole, Hyderabad, Telangana, India – 500068.